XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net (loss) income from continuing operations $ (57,559) $ 6,954
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation 11,019 7,993
Amortization 11,969 14,793
Stock-based compensation 38,399 34,906
Non-cash interest expense 4,144 12,324
Deferred tax provision (benefit) 14,386 (5,435)
Loss on extinguishment of debt 215 0
Other 651 3,028
Changes in operating assets and liabilities, excluding effects of acquisitions:    
Accounts receivable (19,354) (40,023)
Prepaid expenses and other assets 40,930 (5,892)
Accounts payable (14,934) 11,636
Accrued expenses and other liabilities (29,480) (9,480)
Deferred revenue 13,464 23,814
Net cash provided by operating activities - continuing operations 13,850 54,618
Net cash provided by operating activities - discontinued operations 0 6,570
Net cash provided by operating activities 13,850 61,188
Cash flows from investing activities:    
Capital expenditures (12,394) (17,400)
Purchases of marketable securities and other investments 0 (41,366)
Proceeds from sales and maturities of marketable securities and other investments 22,162 37,582
Payments for business and asset acquisitions, net of cash acquired (5,375) (250)
Other 209 (545)
Net cash provided by (used in) investing activities 4,602 (21,979)
Cash flows from financing activities:    
Repurchase and redemption of debt (28,646) 0
Payments for taxes related to net share settlement of equity awards (82,763) (43,729)
Other financing activities (78) (6)
Net cash used in financing activities (111,487) (43,735)
Effects of exchange rate changes on cash and cash equivalents (2,323) 2,739
Net decrease in cash and cash equivalents (95,358) (1,787)
Cash and cash equivalents at beginning of period 187,307 301,233
Cash and cash equivalents at end of period $ 91,949 $ 299,446